Breaking News
Get 40% Off 0
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One Click Copy for Free
Close

TissueGene Inc (950160)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12,550 +200    +1.62%
16:42:57 - Closed. Currency in KRW ( Disclaimer )
  • Volume: 52,927
  • Bid/Ask: 12,530 / 12,550
  • Day's Range: 12,270 - 12,550
Type:  Equity
Market:  South Korea
ISIN:  KR8840120008 
TissueGene 12,550 +200 +1.62%

TissueGene Inc Company Profile

 
Get an in-depth profile of TissueGene Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

DRC

Kolon TissueGene, Inc. engages in developing cell therapies to target various orthopedic diseases and degenerative disorders. The company develops cell therapies for osteoarthritis, including knee and hip; musculoskeletal system disorder comprising spinal disk; and vet medicine for knee. It also has collaboration with Kolon Life Science, Inc. The company was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. Kolon TissueGene, Inc. was founded in 1999 and is based in Rockville, Maryland.

Contact Information

Address 9713 Key West Avenue Suite 300
Rockville, 20850
United States
Phone 301 921 6000
Fax 301 921 6011

Top Executives

Name Age Since Title
David Hunter - 2016 Member of Scientific Advisory Board
Philip G. Conaghan - 2017 Member of Scientific Advisory Board
Peter Shin - - Member of Business Advisory Board
Javad Parvizi - - Member of Clinical Advisory Board
Michael A. Mont - - Member of Clinical Advisory Board
Jung In Kim - 2021 CFO & Director
Terry L. Lierman 74 - Member of Business Advisory Board
Moon-jong Noh - 2001 Co-CEO, Co-President & Director
Sung Han - 2020 Co-CEO, Co-President & Director
Ali Mobasheri - 2020 Member of the Scientific Advisory Board
SunJoo Lee - 2023 Independent Outside Director
Young J. Kim - 2021 Statutory Auditor & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

950160 Comments

Write your thoughts about TissueGene Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email